Showing results (281-290 of 407) with videos related to

Sort By:
Pageof 41
Rheumatology and Therapy|February 3, 2022
Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported OutcomesEugen Feist, Xenofon Baraliakos, Frank Behrens, et al.
Arthritis Care & Research|April 24, 2013
Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritisFrank Behrens, Hans-Peter Tony, Rieke Alten, et al.
Rheumatology (Oxford, England)|October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 1 studyLars Erik Kristensen, Mauro Keiserman, Kim Papp, et al.
Rheumatology (Oxford, England)|July 28, 2018
Safety and efficacy of ixekizumab in patients with PsA and previous inadequate response to TNF inhibitors: week 52 results from SPIRIT-P2Mark C Genovese, Benard Combe, Joel M Kremer, et al.
RMD Open|October 10, 2022
Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccinationElisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, et al.
Expert Opinion on Biological Therapy|June 21, 2024
Pharmacokinetics and safety of candidate tocilizumab biosimilar CT-P47 administered by auto-injector or pre-filled syringe: a randomized, open‑label, single-dose phase I studyKyung-Sang Yu, Hyunwook Ryu, Dongseong Shin, et al.
RMD Open|March 10, 2023
Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpAAnne Constanze Regierer, Anja Weiß, Fabian Proft, et al.
Vaccines|February 26, 2026
Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported StudyKarolina Gente, Benedikt Ditz, Eike Bormann, et al.
Arthritis and Rheumatism|April 9, 2005
Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)Christian E Antoni, Arthur Kavanaugh, Bruce Kirkham, et al.
Annals of the Rheumatic Diseases|November 18, 2010
Involvement of functional autoantibodies against vascular receptors in systemic sclerosisGabriela Riemekasten, Aurélie Philippe, Melanie Näther, et al.
Pageof 41